Linked Data API

Show Search Form

Search Results

77264
star this property registered interest false more like this
star this property date less than 2014-07-10more like thismore than 2014-07-10
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
unstar this property answering dept sort name Health more like this
star this property hansard heading Lyme Disease more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government when the testing of the cerebrospinal fluid of patients suspected of having Lyme disease using the Trinity Biotech kit at the Health Protection Agency’s Lyme Borreliosis Unit began; how many patients' samples were tested in that way; and how many patients were recorded as being positive over that period of time. more like this
star this property tabling member printed
The Countess of Mar more like this
star this property uin HL998 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2014-07-24more like thismore than 2014-07-24
star this property answer text <p>The Trinity Biotech blot has been in use since 2007 by the former Health Protection Agency's Lyme Borreliosis Unit for testing cerebrospinal fluid (CSF) and proved very reliable. It has also been used in this way by other laboratories in Europe. However, CSF antibodies will not be present if there is no evidence of any other antibodies in the serum. Data is not collected centrally on specific samples from patients as the final diagnosis is made by the clinician on the basis of the test results and the clinical presentation.</p> more like this
unstar this property answering member printed Earl Howe more like this
star this property question first answered
less than 2014-07-24T12:31:17.2846277Zmore like thismore than 2014-07-24T12:31:17.2846277Z
star this property answering member
2000
star this property label Biography information for Earl Howe more like this
star this property tabling member
1861
unstar this property label Biography information for The Countess of Mar more like this
386888
star this property registered interest false more like this
star this property date less than 2015-07-01more like thismore than 2015-07-01
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
unstar this property answering dept sort name Health more like this
star this property hansard heading Amyloidosis more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government which of the four phase 2 or 3 clinical trials for systemic amyloidosis approved since 2004 are still ongoing; and whether any of the trials have produced sufficient positive outcomes to encourage commercial development. more like this
star this property tabling member printed
Lord Willis of Knaresborough more like this
star this property uin HL997 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-07-14more like thismore than 2015-07-14
star this property answer text <p>There are four trials for systemic amyloidosis that are designated as ‘ongoing’ in the United Kingdom. These are being conducted by two commercial sponsors, Millennium Pharmaceuticals Inc and A.T. Development Switzerland Sarl (two studies), and one non-commercial sponsor, European Myeloma Network.</p><p> </p><p> </p><p> </p><p>Clinical trial sponsors are required to publish a summary of their trial results to the EU Clinical Trials Register within one year of their trial completing. At that point, these results will become publically available on the EU Clinical Trials Register</p><p> </p><p> </p><p> </p><p>The Department of Health, which funds the National Institute for Health Research (NIHR), is a member of the National Cancer Research Institute (NCRI). NCRI Clinical Studies Groups (CSGs) bring together clinicians, scientists, statisticians and lay representatives to coordinate development of a strategic portfolio of trials within their field. All CSGs interact with clinical research networks, funders (including NIHR) and researchers to develop studies aimed at improving outcomes for patients. The Haematological Oncology CSG has a Myeloma Subgroup and its 2013-14 annual report that includes an assessment of progress in these areas is attached and available on the NCRI website at:</p><p> </p><p><a href="http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf" target="_blank">http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf</a>.</p><p> </p><p> </p><p> </p><p>We cannot comment on commercial considerations. When the results are known, the commercial potential of these trial’s products will be a matter for the respective trial sponsors.</p><p> </p>
unstar this property answering member printed Lord Prior of Brampton more like this
star this property grouped question UIN
HL995 more like this
HL996 more like this
star this property question first answered
less than 2015-07-14T15:34:29.553Zmore like thismore than 2015-07-14T15:34:29.553Z
star this property answering member
127
star this property label Biography information for Lord Prior of Brampton more like this
star this property attachment
1
unstar this property file name NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf more like this
star this property title 2013-14 Annual Report more like this
star this property tabling member
4151
unstar this property label Biography information for Lord Willis of Knaresborough more like this
533033
star this property registered interest false more like this
star this property date less than 2016-07-05more like thismore than 2016-07-05
star this property answering body
Department for Communities and Local Government more like this
star this property answering dept id 7 more like this
star this property answering dept short name Communities and Local Government more like this
unstar this property answering dept sort name Communities and Local Government more like this
star this property hansard heading EP Committee of Inquiry into Money Laundering, Tax Avoidance and Tax Evasion more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government what assessment they have made of the impact of administrative and immigration check fees on those on low incomes seeking to rent a home. more like this
star this property tabling member printed
Lord Roberts of Llandudno more like this
star this property uin HL997 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2016-07-13more like thismore than 2016-07-13
star this property answer text <p>Not all letting agents charge fees for right to rent checks and when right to rent was rolled out in the West Midlands, it was found that the majority of letting agents were not charging a fee for conducting the right to rent immigration checks. Letting agents are required to be fully transparent about their fees and publicise a complete tariff of fees in their offices and on their website. The Government believes that full transparency gives consumers the information they need. We intend to carry out a review later this year into how well this approach is working.</p> more like this
unstar this property answering member printed Baroness Williams of Trafford more like this
star this property question first answered
less than 2016-07-13T15:42:31.19Zmore like thismore than 2016-07-13T15:42:31.19Z
star this property answering member
4311
star this property label Biography information for Baroness Williams of Trafford more like this
star this property tabling member
3691
unstar this property label Biography information for Lord Roberts of Llandudno more like this
753309
star this property registered interest false more like this
star this property date less than 2017-07-18more like thismore than 2017-07-18
star this property answering body
HM Treasury more like this
star this property answering dept id 14 more like this
star this property answering dept short name Treasury more like this
unstar this property answering dept sort name CaTreasury more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text Her Majesty's Government what steps they have taken, if any, to engage with the European Parliament's inquiry into Money Laundering, Tax Avoidance and Tax Evasion. more like this
star this property tabling member printed
Lord Kennedy of Southwark more like this
star this property uin HL997 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2017-07-28more like thismore than 2017-07-28
star this property answer text <p>The Government has engaged constructively with the European Parliament's Committee of Inquiry into Money Laundering, Tax Avoidance and Tax Evasion‎.</p><p> </p><p>In February 2017, the previous Financial Secretary to the Treasury and the previous Economic Secretary to the Treasury wrote to the Chair of the European Parliament to set out the extensive recent steps the UK had taken in these areas. In the same month, Members of the Committee visited London and met with senior officials from the UK's cross-agency Panama Papers Taskforce to discuss their important work.</p> more like this
unstar this property answering member printed Lord Bates more like this
star this property question first answered
less than 2017-07-28T12:33:37.203Zmore like thismore than 2017-07-28T12:33:37.203Z
star this property answering member
1091
star this property label Biography information for Lord Bates more like this
star this property tabling member
4153
unstar this property label Biography information for Lord Kennedy of Southwark more like this
77263
star this property registered interest false more like this
star this property date less than 2014-07-10more like thismore than 2014-07-10
star this property answering body
Home Office more like this
star this property answering dept id 1 more like this
star this property answering dept short name Home Office more like this
unstar this property answering dept sort name Home Office more like this
star this property hansard heading Harmondsworth Immigration Removal Centre more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government whether, following the Independent Monitoring Board's Annual Report 2013, they have initiated changes at Harmondsworth Immigration Removal Centre to ensure that detainees claiming to be under 18 are assessed by social services in the community rather than in the centre. more like this
star this property tabling member printed
Baroness Stern more like this
star this property uin HL997 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2014-07-23more like thismore than 2014-07-23
star this property answer text <p>The Independent Monitoring Board (IMB) for Harmondsworth published its 2013 report on 30 June. An action plan to address the recommendations in the report will be agreed by 11 August. Plans to make changes to the configuration of the healthcare unit to address the provision of appropriate accommodation for those with mental health or behavioural problems are under discussion with the new healthcare provider at Harmondsworth. This is in advance of the transfer of healthcare commissioning to NHS England on 1 September. Individuals who claim to be under the age of 18 following their detention are managed in accordance with Detention Services Order 14/2012 for the care and management of age dispute cases. This sets out the policy and procedures to follow in individual cases where there is a lack of physical or definitive documentary evidence to prove the person is under the age of 18. This also details the circumstances in which release by case owners is appropriate.</p> more like this
unstar this property answering member printed Lord Taylor of Holbeach more like this
star this property question first answered
less than 2014-07-23T13:10:51.946498Zmore like thismore than 2014-07-23T13:10:51.946498Z
star this property answering member
3787
star this property label Biography information for Lord Taylor of Holbeach more like this
star this property tabling member
2475
unstar this property label Biography information for Baroness Stern more like this
386887
star this property registered interest false more like this
star this property date less than 2015-07-01more like thismore than 2015-07-01
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
unstar this property answering dept sort name Health more like this
star this property hansard heading Amyloidosis more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government whether there are currently any trials for systemic amyloidosis in humans being conducted by the National Institute of Health Research charities or the commercial sector. more like this
star this property tabling member printed
Lord Willis of Knaresborough more like this
star this property uin HL996 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-07-14more like thismore than 2015-07-14
star this property answer text <p>There are four trials for systemic amyloidosis that are designated as ‘ongoing’ in the United Kingdom. These are being conducted by two commercial sponsors, Millennium Pharmaceuticals Inc and A.T. Development Switzerland Sarl (two studies), and one non-commercial sponsor, European Myeloma Network.</p><p> </p><p> </p><p> </p><p>Clinical trial sponsors are required to publish a summary of their trial results to the EU Clinical Trials Register within one year of their trial completing. At that point, these results will become publically available on the EU Clinical Trials Register</p><p> </p><p> </p><p> </p><p>The Department of Health, which funds the National Institute for Health Research (NIHR), is a member of the National Cancer Research Institute (NCRI). NCRI Clinical Studies Groups (CSGs) bring together clinicians, scientists, statisticians and lay representatives to coordinate development of a strategic portfolio of trials within their field. All CSGs interact with clinical research networks, funders (including NIHR) and researchers to develop studies aimed at improving outcomes for patients. The Haematological Oncology CSG has a Myeloma Subgroup and its 2013-14 annual report that includes an assessment of progress in these areas is attached and available on the NCRI website at:</p><p> </p><p><a href="http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf" target="_blank">http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf</a>.</p><p> </p><p> </p><p> </p><p>We cannot comment on commercial considerations. When the results are known, the commercial potential of these trial’s products will be a matter for the respective trial sponsors.</p><p> </p>
unstar this property answering member printed Lord Prior of Brampton more like this
star this property grouped question UIN
HL995 more like this
HL997 more like this
star this property question first answered
less than 2015-07-14T15:34:29.297Zmore like thismore than 2015-07-14T15:34:29.297Z
star this property answering member
127
star this property label Biography information for Lord Prior of Brampton more like this
star this property attachment
1
unstar this property file name NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf more like this
star this property title 2013-14 Annual Report more like this
star this property tabling member
4151
unstar this property label Biography information for Lord Willis of Knaresborough more like this
533032
star this property registered interest false more like this
star this property date less than 2016-07-05more like thismore than 2016-07-05
star this property answering body
Foreign and Commonwealth Office more like this
star this property answering dept id 16 more like this
star this property answering dept short name Foreign and Commonwealth Office more like this
unstar this property answering dept sort name Foreign and Commonwealth Office more like this
star this property hansard heading Public Sector Debt more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government what steps they are taking to encourage Gulf States to accept Syrian asylum seekers. more like this
star this property tabling member printed
Lord Roberts of Llandudno more like this
star this property uin HL996 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2016-07-13more like thismore than 2016-07-13
star this property answer text We recognise and welcome the substantial and continued contribution made by Gulf Cooperation Council (GCC) states to the humanitarian aid response for Syria and the large numbers of Syrians already in the Gulf. The Gulf states are now home to almost one million Syrians, and Gulf states have pledged more than $3 billion in humanitarian assistance. Kuwait co-hosted the London Donor Conference in February 2016 where Gulf states pledged $739 million. more like this
unstar this property answering member printed Baroness Anelay of St Johns more like this
star this property question first answered
less than 2016-07-13T15:15:45.427Zmore like thismore than 2016-07-13T15:15:45.427Z
star this property answering member
3474
star this property label Biography information for Baroness Anelay of St Johns more like this
star this property tabling member
3691
unstar this property label Biography information for Lord Roberts of Llandudno more like this
753308
star this property registered interest false more like this
star this property date less than 2017-07-18more like thismore than 2017-07-18
star this property answering body
HM Treasury more like this
star this property answering dept id 14 more like this
star this property answering dept short name Treasury more like this
unstar this property answering dept sort name CaTreasury more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text Her Majesty's Government what progress have they made in reducing the national debt. more like this
star this property tabling member printed
Lord Kennedy of Southwark more like this
star this property uin HL996 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2017-07-28more like thismore than 2017-07-28
star this property answer text <p>In 2010 the government inherited the largest deficit since the Second World War at 9.9% of GDP in 2009-10. Since then the government has reduced the deficit by three quarters to 2.4% of GDP last year. Without this reduction the level of debt would be even higher than its level of 86.8% of GDP at the end of March 2017.</p><p> </p><p>The government has committed to ensure Public Sector Net Debt as a share of GDP is falling in 2020-21. In their March 2017 forecast the Office for Budget Responsibility forecast that the government will meet this target two years early in 2018-19.</p> more like this
unstar this property answering member printed Lord Bates more like this
star this property question first answered
less than 2017-07-28T12:33:52.503Zmore like thismore than 2017-07-28T12:33:52.503Z
star this property answering member
1091
star this property label Biography information for Lord Bates more like this
star this property tabling member
4153
unstar this property label Biography information for Lord Kennedy of Southwark more like this
77262
star this property registered interest false more like this
star this property date less than 2014-07-10more like thismore than 2014-07-10
star this property answering body
Home Office more like this
star this property answering dept id 1 more like this
star this property answering dept short name Home Office more like this
unstar this property answering dept sort name Home Office more like this
star this property hansard heading Harmondsworth Immigration Removal Centre more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what plans they have to respond to the Independent Monitoring Board's Annual Report 2013 on Harmondsworth Immigration Removal Centre and in particular its finding in respect of the provision of appropriate accommodation for those with mental health or behavioural problems. more like this
star this property tabling member printed
Baroness Stern more like this
star this property uin HL996 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2014-07-22more like thismore than 2014-07-22
star this property answer text <p>The Independent Monitoring Board (IMB) for Harmondsworth published its 2013 report on 30 June. An action plan to address the recommendations in the report will be agreed by 11 August. Plans to make changes to the configuration of the healthcare unit to address the provision of appropriate accommodation for those with mental health or behavioural problems are under discussion with the new healthcare provider at Harmondsworth. This is in advance of the transfer of healthcare commissioning to NHS England on 1 September. Individuals who claim to be under the age of 18 following their detention are managed in accordance with Detention Services Order 14/2012 for the care and management of age dispute cases. This sets out the policy and procedures to follow in individual cases where there is a lack of physical or definitive documentary evidence to prove the person is under the age of 18. This also details the circumstances in which release by case owners is appropriate.</p> more like this
unstar this property answering member printed Lord Taylor of Holbeach more like this
star this property question first answered
less than 2014-07-22T17:28:25.6494589Zmore like thismore than 2014-07-22T17:28:25.6494589Z
star this property answering member
3787
star this property label Biography information for Lord Taylor of Holbeach more like this
star this property tabling member
2475
unstar this property label Biography information for Baroness Stern more like this
386886
star this property registered interest false more like this
star this property date less than 2015-07-01more like thismore than 2015-07-01
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
unstar this property answering dept sort name Health more like this
star this property hansard heading Bone Marrow Disorders more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government whether they will place in the Library of the House any publications resulting from the phase 3 clinical trials approved for the potential treatment of systemic amyloidosis or multiple myeloma; and what is the National Institute of Health Research’s assessment of progress in these areas. more like this
star this property tabling member printed
Lord Willis of Knaresborough more like this
star this property uin HL995 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-07-14more like thismore than 2015-07-14
star this property answer text <p>There are four trials for systemic amyloidosis that are designated as ‘ongoing’ in the United Kingdom. These are being conducted by two commercial sponsors, Millennium Pharmaceuticals Inc and A.T. Development Switzerland Sarl (two studies), and one non-commercial sponsor, European Myeloma Network.</p><p> </p><p> </p><p> </p><p>Clinical trial sponsors are required to publish a summary of their trial results to the EU Clinical Trials Register within one year of their trial completing. At that point, these results will become publically available on the EU Clinical Trials Register</p><p> </p><p> </p><p> </p><p>The Department of Health, which funds the National Institute for Health Research (NIHR), is a member of the National Cancer Research Institute (NCRI). NCRI Clinical Studies Groups (CSGs) bring together clinicians, scientists, statisticians and lay representatives to coordinate development of a strategic portfolio of trials within their field. All CSGs interact with clinical research networks, funders (including NIHR) and researchers to develop studies aimed at improving outcomes for patients. The Haematological Oncology CSG has a Myeloma Subgroup and its 2013-14 annual report that includes an assessment of progress in these areas is attached and available on the NCRI website at:</p><p> </p><p><a href="http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf" target="_blank">http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf</a>.</p><p> </p><p> </p><p> </p><p>We cannot comment on commercial considerations. When the results are known, the commercial potential of these trial’s products will be a matter for the respective trial sponsors.</p><p> </p>
unstar this property answering member printed Lord Prior of Brampton more like this
star this property grouped question UIN
HL996 more like this
HL997 more like this
star this property question first answered
less than 2015-07-14T15:34:29.197Zmore like thismore than 2015-07-14T15:34:29.197Z
star this property answering member
127
star this property label Biography information for Lord Prior of Brampton more like this
star this property attachment
1
unstar this property file name NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf more like this
star this property title 2013-14 Annual Report more like this
star this property tabling member
4151
unstar this property label Biography information for Lord Willis of Knaresborough more like this